Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
Clinical trial NCT05775848 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05775848
- Sponsor
- ML Bio Solutions, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2027-07-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.